A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

Clinical trial NCT06941480 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06941480
Sponsor: Memorial Sloan Kettering Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Tumor of the Lung Neuroendocrine Carcinoma of Lung Neuroendocrine Carcinoma Neuroendocrine Carcinoma of Prostate

Start date: 2026-09-01
Primary completion: 2030-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.